As designers of therapeutic proteins and antibodies, how can we take advantage of an immunological “short-cut”, to make our molecules less immunogenic?
Read MoreIt’s often widely assumed that decisions made by algorithms are more “neutral” and “fair” than those made by people.
Read MoreActionable insights that can be gained by the application of Bayesian analysis to the design of biomarkers ...
Read MoreA story about how a challenging genome sequencing project demonstrated once again, what an awesome tool Python can be ...
Read More